These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 30067278)

  • 1. Transcatheter closure of atrial septal communication: impact on P-wave dispersion, duration, and arrhythmia in mid-term follow-up.
    Lelakowska M; Komar M; Matusik PT; Nessler J; Podolec P; Olszowska M
    Kardiol Pol; 2018; 76(10):1465-1473. PubMed ID: 30067278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcatheter closure of atrial septal communication: Impact on quality of life in mid-term follow-up.
    Lelakowska M; Matusik PT; Podolec PS; Olszowska M; Nessler JM; Podolec N; Przewłocki T; Komar M
    Adv Clin Exp Med; 2019 Aug; 28(8):1079-1085. PubMed ID: 31237120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial septal defect and patent foramen ovale: early and long-term effects on endothelial function after percutaneous occlusion procedure.
    Scicchitano P; Gesualdo M; Cortese F; Acquaviva T; de Cillis E; Bortone AS; Ciccone MM
    Heart Vessels; 2019 Sep; 34(9):1499-1508. PubMed ID: 30895384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Percutaneous Closure of Interatrial Shunts on Migraine Attacks: Single-Operator Series and Review of the Literature.
    Manolis AS
    Rev Recent Clin Trials; 2017; 12(2):129-138. PubMed ID: 28356032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous closure of inter-atrial communications (atrial septal defect and patent foramen ovale): single-centre experience and mid-term follow-up.
    Van de Bruaene A; Stroobants D; Benit E
    Acta Cardiol; 2015 Apr; 70(2):133-40. PubMed ID: 26148372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left atrial appendage closure for "primary primary" prevention during percutaneous closure of septal defects in patients with large atria but no atrial fibrillation.
    Kuwata S; Vierecke J; Gloekler S; Maisano F; Meier B; Nietlispach F
    Cardiol J; 2018; 25(2):179-187. PubMed ID: 28840592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrocardiographic changes and arrhythmias following percutaneous atrial septal defect and patent foramen ovale device closure.
    Johnson JN; Marquardt ML; Ackerman MJ; Asirvatham SJ; Reeder GS; Cabalka AK; Cetta F; Hagler DJ
    Catheter Cardiovasc Interv; 2011 Aug; 78(2):254-61. PubMed ID: 21563292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcatheter interatrial septal defect closure in a large cohort: midterm follow-up results.
    Aytemir K; Oto A; Özkutlu S; Canpolat U; Kaya EB; Yorgun H; Şahiner L; Sunman H; Ateş AH; Kabakçı G
    Congenit Heart Dis; 2013; 8(5):418-27. PubMed ID: 23601507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maximum p wave duration and p wave dispersion in adult patients with secundum atrial septal defect: the impact of surgical repair.
    Guray U; Guray Y; Mecit B; Yilmaz MB; Sasmaz H; Korkmaz S
    Ann Noninvasive Electrocardiol; 2004 Apr; 9(2):136-41. PubMed ID: 15084210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of atrial fibrillation after percutaneous closure of patent foramen ovale and small atrial septal defects in patients presenting with cryptogenic stroke.
    Bonvini RF; Sztajzel R; Dorsaz PA; Righini M; Bonvin C; Alibegovic J; Sigwart U; Camenzind E; Verin V; Sztajzel J
    Int J Stroke; 2010 Feb; 5(1):4-9. PubMed ID: 20088986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracardiac echo-guided radiofrequency catheter ablation of atrial fibrillation in patients with atrial septal defect or patent foramen ovale repair: a feasibility, safety, and efficacy study.
    Lakkireddy D; Rangisetty U; Prasad S; Verma A; Biria M; Berenbom L; Pimentel R; Emert M; Rosamond T; Fahmy T; Patel D; Di Biase L; Schweikert R; Burkhardt D; Natale A
    J Cardiovasc Electrophysiol; 2008 Nov; 19(11):1137-42. PubMed ID: 18662188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of cerebral embolism after interventional closure of symptomatic patent foramen ovale or atrial septal defect: a diffusion-weighted MRI and neuron-specific enolase-based study.
    Oktay Tureli H; Ungan I; Tureli D; Demir B; Pirhan O; Bayrak HI; Caglar IM; Karakaya O; Inci E
    J Invasive Cardiol; 2013 Oct; 25(10):519-24. PubMed ID: 24088426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for atrial fibrillation in adult patients in long-term observation following surgical closure of atrial septal defect type II.
    Piechowiak M; Banach M; Ruta J; Barylski M; Rysz J; Bartczak K; Markuszewski L; Zasłonka J; Goch JH
    Thorac Cardiovasc Surg; 2006 Jun; 54(4):259-63. PubMed ID: 16755448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of atrial fibrillation after transcatheter closure of patent foramen ovale in patients with or without cryptogenic stroke.
    Bronzetti G; D'Angelo C; Donti A; Salomone L; Giardini A; Maria Picchio F; Boriani G
    Int J Cardiol; 2011 Jan; 146(1):17-21. PubMed ID: 19487038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of atrial fibrillation following transcatheter closure of atrial septal defects in adults.
    Spies C; Khandelwal A; Timmermanns I; Schräder R
    Am J Cardiol; 2008 Oct; 102(7):902-6. PubMed ID: 18805119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of percutaneous atrial septal defect and patent foramen ovale device closure on degree of aortic regurgitation.
    Loar RW; Johnson JN; Cabalka AK; Cetta F; Hagler DJ; Eidem BW; Taggart NW
    Catheter Cardiovasc Interv; 2013 Jun; 81(7):1234-7. PubMed ID: 23239614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous closure of patent foramen ovale and atrial septal defect: procedure outcome and medium-term follow-up.
    Egred M; Andron M; Albouaini K; Alahmar A; Grainger R; Morrison WL
    J Interv Cardiol; 2007 Oct; 20(5):395-401. PubMed ID: 17880337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malattached septum primum and deficient septal rim predict unsuccessful transcatheter closure of atrial communications.
    Ostermayer SH; Srivastava S; Doucette JT; Ko HH; Geiger M; Parness IA; Love BA
    Catheter Cardiovasc Interv; 2015 Dec; 86(7):1195-203. PubMed ID: 26332722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracardiac echocardiographic guidance during transcatheter device closure of atrial septal defect and patent foramen ovale.
    Earing MG; Cabalka AK; Seward JB; Bruce CJ; Reeder GS; Hagler DJ
    Mayo Clin Proc; 2004 Jan; 79(1):24-34. PubMed ID: 14708945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous closure of atrial septal defects: immediate and mid-term results.
    Dardas PS; Ninios VN; Mezilis NE; Tsikaderis DD; Thanopoulos VD
    Hellenic J Cardiol; 2010; 51(2):104-12. PubMed ID: 20378511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.